Silicon and Silicone Levels in Patients with Silicone Implants
Although a potential link between silicone gel breast implants and autoimmune connective tissue disease has been suggested, none has been proven. The potential role of silicone as an immune adjuvant remains very controversial. Currently available techniques do not easily allow precise measurements of silicone in tissues. However, all compounds containing silicon (which would include silicone) can be measured accurately. The present study was designed to measure silicon levels in the fibrous capsules of patients with silicone-gel breast implants, saline breast implants and silicone inflatable penile prostheses. Baseline control silicon levels were obtained from the breast tissue of patients undergoing breast reduction, who had no exposure to breast implants. All silicon measurements were carried out using atomic absorption spectrometry with a graphite furnace.
The mean silicon levels in 16 breast tissue control samples from 8 patients undergoing breast reduction varied from 0.046 to 0.742 μg/g dry weight, with the median mean being 0.0927. The median silicon level in capsules from 6 patients with saline implants was 7.7 μg/g (range 36.6). The median silicon level in capsules from 5 patients with silicone inflatable penile prostheses was 19.5 μg/g (range 34.8). Although the levels of silicon in capsules of patients with saline breast prostheses and penile implants were higher than in control samples, they were much lower than those from the capsules of the 58 gel implants (median 9979 μg/g).
Of the 58 silicone gel breast implants (from 20 patients with bilateral implant removal and 18 patients with unilateral removal) which had been inserted from 1974 to 1990, 28 were intact, 8 had pinhole leaks, and 22 were ruptured. Median capsule silicon levels and ranges for all 58 implants, for intact only, for leaking, and for ruptured were: 9979 (152,000), 10,477 (88,703), 6592 (65,396), and 9922 (152,387) μg/g respectively. There were no significant differences in silicon levels associated with implant status, duration in situ, or year of implantation. Capsule contracture was not associated with higher levels of capsule silicon. Capsule silicon levels were about 106 times higher than previously assayed blood silicon levels. This may be because silicone released from implants remains localized in cap-sular tissue, or because blood-borne silicone is quickly excreted. Using 29Si nuclear magnetic resonance spectroscopy, no detectable silicone was found in the blood of 7 control women and 7 women with silicone-gel implants (5 with known implant rupture).
KeywordsMagic Angle Spin Breast Implant Penile Prosthesis 29Si Nuclear Magnetic Resonance Silicon Level
Unable to display preview. Download preview PDF.
- 1.FDA Hearing: General and Plastic Surgery Devices Panel Meeting (1992) Transcript Vol I: 1–459, Vol II: 1-560, Vol III: 1-362.Google Scholar
- 2.Callahan T(1992) Tensile strength and liquid silicone bleed in FDA General Plastic Surgery Devices Panel Meeting. Transcript Vol I: 73–84.Google Scholar
- 5.LeVier RR. (1992) Dow Corning presentation in FDA General Plastic Surgery Devices Panel Meeting Transcript Vol II: 31–49,142,219.Google Scholar
- 6.Baines CJ, Arseneau J, Smith DC. (1992) Summary of the report on silicone gel-filled breast implants Can Med Assoc J 147:1141–1146.Google Scholar
- 9.de Camara DL, Sheridan JM, Kammer BA (1993) Rupture and aging of silicone gel breast implants. Plast Reconstr Surg 91:829–834.Google Scholar
- 15.Peters WJ, Smith D, Lugowski S, McHugh A, Keresteci A, Baines C (1995) An analysis of silicon levels in capsules of gel and saline breast implants and of penile prostheses. Ann Plast Surg, in press.Google Scholar
- 16.Dobbie JW, Smith MJB. Urinary and serum silicon in normal and uremic individuals. In: Evered D, O’Connor M (1986) Silicon Biochemistry: Ciba Foundation Symposium 121. New York: Wiley 194–213.Google Scholar
- 17.Carlisle EM (1986) Silicon as an essential trace element in animal nutrition. In: Silicon Biochemistry. Ciba Foundation Symposium 121. Evered D, O’Connor M (ed). New York: John Wiley and Sons 123–129.Google Scholar
- 21.Barrett DM, O’Sullivan D, Malizia AA (1991) Particle shedding and migration from silicone genito-urinary prosthetic devices. J Urolog 146:319–322.Google Scholar
- 22.Nairn JO, van Oss CJ, Lanzafame RJ (1993) The induction of autoantibodies to thyroglobulin in rats with silicone gel as adjuvant. Surg Forum 44:676–678.Google Scholar
- 23.Rose NR. Invited comment (1992) Ann Plast Surg 28:499–501.Google Scholar
- 24.LeVier RR, Harrison MC, Cook RR, Lane TH (1993) What is silicone? Plast Reconstr Surg 92:163–167.Google Scholar